Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Investigating novel chloride conductance activators for cystic fibrosis: Molecular docking and pharmacokinetics analysis of 3- (2-benzyloxy phenyl)isoxazoles and isoxazolines derivatives

2026In Silico Research in BiomedicineJournalOpen access

10.1016/j.insi.2026.100211 Full text0 citations

Authors

5 authors across 3 institutions in 2 countries.

Muhammad Suleiman DarmaFirst author
- Federal Medical Centre (NG)
- Ahmadu Bello University (NG)
Adamu UzairuCorresponding
- Ahmadu Bello University (NG)
Muhammad Tukur Ibrahim
- Ahmadu Bello University (NG)
Harsha Jadhav
Ibrahim AbdulkadirSenior author
- Ahmadu Bello University (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Cystic Fibrosis Research Advanceslevel 3 · 0.98
Computational Drug Discovery Methodslevel 3 · 0.00
Drug Transport and Resistance Mechanismslevel 3 · 0.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2026 · In Silico Research in Biomedicine · 0 citations
https://openalex.org/W7126030840

Investigating novel chloride conductance activators for cystic fibrosis: Molecular docking and pharmacokinetics analysis of 3- (2-benzyloxy phenyl)isoxazoles and isoxazolines derivatives · Sankore